Pricing
Login
Home
Charts
Search
Watchlist
Products

Unichem Laboratories Ltd

UNICHEMLAB
NSE
₹509.15+1.30%9 Nov 2026
Reports
Pharma Others

Unichem Laboratories Ltd

UNICHEMLAB
NSE
₹509.15
+1.30%
9 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹3,585Cr
Close
Close Price
₹509.15
Industry
Industry
Pharma Others
PE
Price To Earnings
10.58
PS
Price To Sales
1.51
Revenue
Revenue
₹2,369Cr
Rev Gr TTM
Revenue Growth TTM
6.44%
PAT Gr TTM
PAT Growth TTM
283.10%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
466432483507533587527579521575633640
Growth YoY
Revenue Growth YoY%
54.07.414.222.114.536.08.914.1-2.2-2.020.110.6
Expenses
ExpensesCr
435406443452448503504513476527563566
Operating Profit
Operating ProfitCr
312540558684226645487074
OPM
OPM%
6.75.98.310.916.014.34.311.48.68.311.111.6
Other Income
Other IncomeCr
79-119491497-372871116-9
Interest Expense
Interest ExpenseCr
654575787978
Depreciation
DepreciationCr
322732323130323131313030
PBT
PBTCr
73-1268276258-9-11293194927
Tax
TaxCr
0363451129885
PAT
PATCr
73-1292255853-10-12264114122
Growth YoY
PAT Growth YoY%
214.5-192.1409.0200.6-21.0141.0-605.8-148.3356.9-79.4496.1286.9
NPM
NPM%
15.7-29.90.44.810.89.0-2.0-2.050.71.96.63.5
EPS
EPS₹
10.4-18.40.33.58.27.5-1.5-1.737.51.65.93.2
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
466432483507533587527579521575633640
Growth YoY
Revenue Growth YoY%
54.07.414.222.114.536.08.914.1-2.2-2.020.110.6
Expenses
ExpensesCr
435406443452448503504513476527563566
Operating Profit
Operating ProfitCr
312540558684226645487074
OPM
OPM%
6.75.98.310.916.014.34.311.48.68.311.111.6
Other Income
Other IncomeCr
79-119491497-372871116-9
Interest Expense
Interest ExpenseCr
654575787978
Depreciation
DepreciationCr
322732323130323131313030
PBT
PBTCr
73-1268276258-9-11293194927
Tax
TaxCr
0363451129885
PAT
PATCr
73-1292255853-10-12264114122
Growth YoY
PAT Growth YoY%
214.5-192.1409.0200.6-21.0141.0-605.8-148.3356.9-79.4496.1286.9
NPM
NPM%
15.7-29.90.44.810.89.0-2.0-2.050.71.96.63.5
EPS
EPS₹
10.4-18.40.33.58.27.5-1.5-1.737.51.65.93.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,3336988151,1801,1041,2351,2701,3431,7852,1112,2022,369
Growth
Revenue Growth%
10.9-47.616.844.9-6.511.92.85.832.918.34.36.4
Expenses
ExpensesCr
1,1697399461,2641,1551,1441,1971,3891,6981,8462,0182,132
Operating Profit
Operating ProfitCr
164-41-132-83-519173-4687265184237
OPM
OPM%
12.3-5.9-16.2-7.1-4.67.45.7-3.44.912.68.410.0
Other Income
Other IncomeCr
15661989250460-2635265305
Interest Expense
Interest ExpenseCr
33888561723213231
Depreciation
DepreciationCr
39445167828491113123125125122
PBT
PBTCr
137-83-130-60-485122-176-85155292389
Tax
TaxCr
29-123-341217-11269174050
PAT
PATCr
108-71-133-26-603433-202-94138253339
Growth
PAT Growth%
43.6-165.4-88.280.8-135.5157.0-3.7-711.753.6246.783.9283.1
NPM
NPM%
8.1-10.1-16.3-2.2-5.52.82.6-15.1-5.36.511.514.3
EPS
EPS₹
11.912.0280.6-3.6-8.64.94.7-28.7-13.319.535.948.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,3336988151,1801,1041,2351,2701,3431,7852,1112,2022,369
Growth
Revenue Growth%
10.9-47.616.844.9-6.511.92.85.832.918.34.36.4
Expenses
ExpensesCr
1,1697399461,2641,1551,1441,1971,3891,6981,8462,0182,132
Operating Profit
Operating ProfitCr
164-41-132-83-519173-4687265184237
OPM
OPM%
12.3-5.9-16.2-7.1-4.67.45.7-3.44.912.68.410.0
Other Income
Other IncomeCr
15661989250460-2635265305
Interest Expense
Interest ExpenseCr
33888561723213231
Depreciation
DepreciationCr
39445167828491113123125125122
PBT
PBTCr
137-83-130-60-485122-176-85155292389
Tax
TaxCr
29-123-341217-11269174050
PAT
PATCr
108-71-133-26-603433-202-94138253339
Growth
PAT Growth%
43.6-165.4-88.280.8-135.5157.0-3.7-711.753.6246.783.9283.1
NPM
NPM%
8.1-10.1-16.3-2.2-5.52.82.6-15.1-5.36.511.514.3
EPS
EPS₹
11.912.0280.6-3.6-8.64.94.7-28.7-13.319.535.948.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181814141414141414141414
Reserves
ReservesCr
9361,0452,6662,6062,5172,5432,6042,4212,4242,4372,7032,767
Current Liabilities
Current LiabilitiesCr
2433934645035675065526407389928861,001
Non Current Liabilities
Non Current LiabilitiesCr
86705027476314811899127134125
Total Liabilities
Total LiabilitiesCr
1,2841,5273,1943,1503,1453,1263,3193,1933,2753,5693,7373,908
Current Assets
Current AssetsCr
6007482,3362,0381,6861,3771,6481,5881,7432,0292,1972,362
Non Current Assets
Non Current AssetsCr
6837788571,1111,4581,7481,6701,6051,5321,5401,5401,542
Total Assets
Total AssetsCr
1,2841,5273,1943,1503,1453,1263,3193,1933,2753,5693,7373,908
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
181814141414141414141414
Reserves
ReservesCr
9361,0452,6662,6062,5172,5432,6042,4212,4242,4372,7032,767
Current Liabilities
Current LiabilitiesCr
2433934645035675065526407389928861,001
Non Current Liabilities
Non Current LiabilitiesCr
86705027476314811899127134125
Total Liabilities
Total LiabilitiesCr
1,2841,5273,1943,1503,1453,1263,3193,1933,2753,5693,7373,908
Current Assets
Current AssetsCr
6007482,3362,0381,6861,3771,6481,5881,7432,0292,1972,362
Non Current Assets
Non Current AssetsCr
6837788571,1111,4581,7481,6701,6051,5321,5401,5401,542
Total Assets
Total AssetsCr
1,2841,5273,1943,1503,1453,1263,3193,1933,2753,5693,7373,908

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
11268-112-3282033-260-8514-74
Investing Cash Flow
Investing Cash FlowCr
-85-1281,648-286-36-7410220350-241192
Financing Cash Flow
Financing Cash FlowCr
-3359-881-2-62-121191-81-1061842
Net Cash Flow
Net Cash FlowCr
-70655-616-78-1623436-42-64198
Free Cash Flow
Free Cash FlowCr
-28-79-271-519-360-254-386-1230-142163
CFO To PAT
CFO To PAT%
103.3-96.484.41,282.5-32.996.1-785.242.1-14.9-5.11.4
CFO To EBITDA
CFO To EBITDA%
68.2-164.785.2392.6-39.036.2-356.6186.816.1-2.62.0
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
11268-112-3282033-260-8514-74
Investing Cash Flow
Investing Cash FlowCr
-85-1281,648-286-36-7410220350-241192
Financing Cash Flow
Financing Cash FlowCr
-3359-881-2-62-121191-81-1061842
Net Cash Flow
Net Cash FlowCr
-70655-616-78-1623436-42-64198
Free Cash Flow
Free Cash FlowCr
-28-79-271-519-360-254-386-1230-142163
CFO To PAT
CFO To PAT%
103.3-96.484.41,282.5-32.996.1-785.242.1-14.9-5.11.4
CFO To EBITDA
CFO To EBITDA%
68.2-164.785.2392.6-39.036.2-356.6186.816.1-2.62.0

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0162,6012,0121,3701,0662,1781,8332,0353,4394,8782,0683,585
Price To Earnings
Price To Earnings
18.623.90.863.455.435.58.210.6
Price To Sales
Price To Sales
1.53.72.51.21.01.81.41.51.92.30.91.5
Price To Book
Price To Book
2.12.50.80.50.40.80.70.81.42.00.81.3
EV To EBITDA
EV To EBITDA
12.4-64.8-11.2-16.4-20.424.328.4-47.540.619.712.316.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.152.144.851.151.858.155.045.848.350.144.244.2
OPM
OPM%
12.3-5.9-16.2-7.1-4.67.45.7-3.44.912.68.410.0
NPM
NPM%
8.1-10.1-16.3-2.2-5.52.82.6-15.1-5.36.511.514.3
ROCE
ROCE%
14.2-6.8-4.3-1.9-1.52.10.9-5.8-2.36.010.112.9
ROE
ROE%
11.3-6.7-5.0-1.0-2.41.31.3-8.3-3.95.69.312.2
ROA
ROA%
8.4-4.6-4.2-0.8-1.91.11.0-6.3-2.93.96.88.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,0162,6012,0121,3701,0662,1781,8332,0353,4394,8782,0683,585
Price To Earnings
Price To Earnings
18.623.90.863.455.435.58.210.6
Price To Sales
Price To Sales
1.53.72.51.21.01.81.41.51.92.30.91.5
Price To Book
Price To Book
2.12.50.80.50.40.80.70.81.42.00.81.3
EV To EBITDA
EV To EBITDA
12.4-64.8-11.2-16.4-20.424.328.4-47.540.619.712.316.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
60.152.144.851.151.858.155.045.848.350.144.244.2
OPM
OPM%
12.3-5.9-16.2-7.1-4.67.45.7-3.44.912.68.410.0
NPM
NPM%
8.1-10.1-16.3-2.2-5.52.82.6-15.1-5.36.511.514.3
ROCE
ROCE%
14.2-6.8-4.3-1.9-1.52.10.9-5.8-2.36.010.112.9
ROE
ROE%
11.3-6.7-5.0-1.0-2.41.31.3-8.3-3.95.69.312.2
ROA
ROA%
8.4-4.6-4.2-0.8-1.91.11.0-6.3-2.93.96.88.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Pharma Others
Market CapitalizationMkt CapCr6,8413,6313,5852,2091,8891,311967
Close PriceClose₹210.8082.05509.15360.6520.10927.55820.50
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE4.1880.4410.5822.094.7419.64
Price To SalesPS3.5432.081.513.283.801.430.91
RevenueRevenueCr1,9321132,3696734989181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%10.3%0.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%-180.2%48.6%317.3%16.8%
Market CapitalizationMkt CapCr6,8413,6313,5852,2091,8891,311967
Close PriceClose₹210.8082.05509.15360.6520.10927.55820.50
IndustryIndustryPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma OthersPharma Others
Price To EarningsPE4.1880.4410.5822.094.7419.64
Price To SalesPS3.5432.081.513.283.801.430.91
RevenueRevenueCr1,9321132,3696734989181,068
Revenue Growth TTMRev Gr TTM%3,141.0%222.2%6.4%10.3%0.4%11.3%42.7%
PAT Growth TTMPAT Gr TTM%712.6%270.5%283.1%-180.2%48.6%317.3%16.8%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews